Publisher
Springer Berlin Heidelberg
Reference94 articles.
1. Aggeler PM, O’Reilly RA, Leong L, Kowitz PE (1967) Potentiation of anticoagulant effect of warfarin by phenylbutazone. N Engl J Med 276:496–501
2. Aguirre C, Rodriguez-Sasiain JM, Calvo R (1994) Decrease in penbutolol protein binding as a consequence of treatment with some alkylating agents. Cancer Chemother Pharmacol 34:86–88
3. Allen LM, Creaven PJ (1974) Binding of a new antitumour agent, thalicorpine to DNA. J Pharm Sci 63:74–475
4. Barre J, Houin G, Brunner RF, Bree F, Tillement JP (1983) Disease induced modifications of drug pharmacokinetics. Int J Clin Pharmacol Res 3:215–226
5. Baruzzi A, Contin M, Perucca E, Albani F, Riva R (1986) Altered serum protein binding of carbamazepine in disease states associated with an increased α1-acid glycoprotein concentration. Eur J Clin Pharmacol 31:85–89
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug Excretion;ADME Processes in Pharmaceutical Sciences;2024
2. Drug Distribution;ADME Processes in Pharmaceutical Sciences;2024
3. Drug Binding to Tissue Components;The ADME Encyclopedia;2022
4. Nonlinear Drug Binding to Plasma Proteins;The ADME Encyclopedia;2022
5. Drug Binding to Plasma Proteins;The ADME Encyclopedia;2022